| | |
Radhieka Pandeya 12:37 AM | August 28,2009
The government’s move will allow people to buy Oseltamivir from designated chemists and other distribution channels if they have a prescription
|
|
Seema Singh 01:15 AM | July 15,2009
Shantha Biotechnics Ltd’s majority stakeholder plans to offload half its holding, but the identity of the likely buyer is something that even founder K.I. Varaprasad Reddy claims he doesn’t know
|
|
Radhieka Pandeya 12:02 AM | July 09,2009
FDA had earlier issued warning letters to firm’s manufacturing plants in India
|
|
C.H. Unnikrishnan 10:35 PM | February 18,2009
GSK Ltd showed income of around Rs30 crore in the quarter as interest earned, mostly from bank deposits and government securities
|
|
10:49 PM | February 22,2008
GSK share on the Bombay Stock Exchange shot up by 2.15% to close Friday trading at Rs953.45
|
|
Bhuma Shrivastava 12:37 AM | January 22,2008
Ranbaxy on Monday said it had settled a lawsuit with the British patent holder, also known as GSK, and will enjoy a six-month market monopoly in the US, beginning Dec
|
|
C.H. Unnikrishnan 12:58 AM | October 10,2007
Trizivir is a fixed-dose combination tablet containing three drugs, lamivudine, zidovudine and abacavir sulfate
|
|
Bhuma Shrivastava 03:19 PM | June 08,2007
The Glaxo unit sells the drug, which has been placed under the sternest warning by FDA, here as Windia
|
|